Evidence map›Paper›PMID 35225054›Full record

ArticleIntegrative cancer therapies

Effects of an Interdisciplinary Integrative Oncology Group-Based Program to Strengthen Resilience and Improve Quality of Life in Cancer Patients: Results of a Prospective Longitudinal Single-Center Study.

Burcu Babadağ Savaş, Bettina Märtens, Holger Cramer, Petra Voiss, Julia Longolius, Axel Weiser, Yvonne Ziert, Hans Christiansen, Diana Steinmann

Abstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Burcu Babadağ SavaşDepartment of Radiation Therapy and Special Oncology, Medical School Hannover, Hannover, Germany.ORCID 0000-0002-5756-5665
Bettina MärtensDepartment of Radiation Therapy and Special Oncology, Medical School Hannover, Hannover, Germany.
Holger CramerUniversity of Duisburg-Essen, Essen, Germany.
Petra VoissUniversity of Duisburg-Essen, Essen, Germany.ORCID 0000-0002-9005-0479
Julia LongoliusDepartment of Radiation Therapy and Special Oncology, Medical School Hannover, Hannover, Germany.
Axel WeiserDepartment of Organisation, Innovation and Quality of Management, Medical School Hannover, Hannover, Germany.
Yvonne ZiertInstitute of Biometrics, Medical School Hannover, Hannover, Germany.
Hans ChristiansenDepartment of Radiation Therapy and Special Oncology, Medical School Hannover, Hannover, Germany.
Diana SteinmannDepartment of Radiation Therapy and Special Oncology, Medical School Hannover, Hannover, Germany.ORCID 0000-0002-5496-3799

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with cancer receiving oncological treatment often suffer from a reduced quality of life (QoL) and resilience.

objectivesThe aim of this study was to evaluate the effect of an interdisciplinary integrative oncology group-based program on resilience and quality of life in patients with cancer during or after conventional oncological therapy.

methodsThis prospective longitudinal single-center study evaluated the resilience (Resilience Scale), quality of life (EORTC-QLQ C30), anxiety, depression (Hospital Anxiety and Depression Scale), and distress levels (Distress Thermometer) of 60 patients with cancer who participated in a 10-week interdisciplinary integrative oncology group-based program during or after cancer treatment in outpatient clinics. An average of 12 (range 11-13) patients participated in each 10-week group. The program included recommendations for diet, stress management, relaxation, and exercise, as well as naturopathic self-help strategies and psychosocial support.

resultsThere were slight increases in global quality of life scores (week 0: 58.05 ± 20.05 vs week 10: 63.13 ± 18.51, n = 59,

conclusionsNo significant effects on global quality of life or resilience were found in the general sample; notably, patients with anxiety and low initial resilience benefited the most from the program.

Indexed as

Integrative OncologyNeoplasmsAnxietyDepressionHumansProspective StudiesQuality of Lifeanxiety and depressioncarecomplementary medicineintegrativelife of qualitynaturopathyoncologyradiotherapyresilience

Identifiers

PMID35225054
PMCPMC8891834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.